Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.
Choose from the criteria below to find an activity that fits you best.
Sexual harassment comes in variety of forms and can severely impact harassed individuals, witnesses, and employers. The consequences of harassment may result in legal issues, reduction in workplace morale, and various health concerns. This written continuing education activity will assist in increasing awareness of what constitutes sexual harassment, the impact of harassment, what do to if you are harassed or a witness, the responsibilities of the employer, and the protections that are place for those reporting harassment.
Shaziya Barkat, PharmD
Memorial Sloan Kettering Cancer Center
New York, NY
Sharon Karina, PharmD
Release Date: December 18, 2019
Expiration Date: December 18, 2022
ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-19-529-H03-P/T has been assigned to this knowledge-based home study CE activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Successful completion of an online post-test and evaluation at www.ProCE.com is required to receive CE credit. No partial credit will be given.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Dr. Barkat and Dr. Karina have no relevant commercial and/or financial relationships to disclose.
No external support was received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.